PortfoliosLab logoPortfoliosLab logo
PAYS vs. TGTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PAYS vs. TGTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in PaySign, Inc. (PAYS) and TG Therapeutics, Inc. (TGTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

The year-to-date returns for both investments are quite close, with PAYS having a 73.98% return and TGTX slightly higher at 74.54%. Over the past 10 years, PAYS has outperformed TGTX with an annualized return of 47.01%, while TGTX has yielded a comparatively lower 24.71% annualized return.


PAYS

1D
-2.18%
1M
4.67%
6M
114.87%
YTD
73.98%
1Y
20.43%
3Y*
68.29%
5Y*
27.49%
10Y*
47.01%
ALL TIME*
14.52%

TGTX

1D
-2.80%
1M
-2.78%
6M
76.79%
YTD
74.54%
1Y
46.56%
3Y*
70.54%
5Y*
8.26%
10Y*
24.71%
ALL TIME*
-7.87%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$4.75M$4.21M$5.00M
$111.05M$115.82M$119.77M

PAYS vs. TGTX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PAYS
PaySign, Inc.
73.98%70.53%7.86%8.53%61.25%-65.52%-54.29%188.35%382.19%118.56%
TGTX
TG Therapeutics, Inc.
74.54%-0.96%76.23%44.38%-37.74%-63.48%368.65%170.73%-50.00%76.34%

Correlation

The correlation between PAYS and TGTX is 0.13, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.13

Correlation (3Y)
Balances recent behavior with more history.

0.18

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.28

Correlation (10Y)
Provides a long-term view across more market conditions.

0.20

Correlation (All Time)
Calculated using the full available price history since May 3, 2010

0.14

The correlation between PAYS and TGTX shifts across timeframes, from 0.13 (1 year) to 0.28 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

PAYS:

$500.92M

TGTX:

$7.96B

EPS

PAYS:

$0.17

TGTX:

$2.88

PE Ratio

PAYS:

52.94

TGTX:

18.04

PEG Ratio

PAYS:

0.45

TGTX:

0.03

PS Ratio

PAYS:

6.02

TGTX:

11.90

PB Ratio

PAYS:

9.94

TGTX:

14.28

Total Revenue (TTM)

PAYS:

$91.47M

TGTX:

$700.35M

Gross Profit (TTM)

PAYS:

$46.93M

TGTX:

$581.54M

EBITDA (TTM)

PAYS:

$22.09M

TGTX:

$156.88M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PAYS vs. TGTX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

PAYS
PAYS Risk / Return Rank: 5757
Overall Rank
PAYS Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
PAYS Sortino Ratio Rank: 5858
Sortino Ratio Rank
PAYS Omega Ratio Rank: 5959
Omega Ratio Rank
PAYS Calmar Ratio Rank: 5555
Calmar Ratio Rank
PAYS Martin Ratio Rank: 5555
Martin Ratio Rank

TGTX
TGTX Risk / Return Rank: 7474
Overall Rank
TGTX Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
TGTX Sortino Ratio Rank: 7373
Sortino Ratio Rank
TGTX Omega Ratio Rank: 7373
Omega Ratio Rank
TGTX Calmar Ratio Rank: 7777
Calmar Ratio Rank
TGTX Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

PAYS vs. TGTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for PaySign, Inc. (PAYS) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PAYSTGTXDifference
Sharpe ratioReturn per unit of total volatility

-0.70

Sortino ratioReturn per unit of downside risk

-0.69

Omega ratioGain probability vs. loss probability

1.13

1.21

-0.08

Calmar ratioReturn relative to maximum drawdown

0.37

1.74

-1.37

Martin ratioReturn relative to average drawdown

0.74

3.46

-2.72

PAYS vs. TGTX - Sharpe Ratio Comparison

The current PAYS Sharpe Ratio is 0.29, which is lower than the TGTX Sharpe Ratio of 0.99. The chart below compares the historical Sharpe Ratios of PAYS and TGTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PAYS vs. TGTX - Drawdown Comparison

The maximum PAYS drawdown since its inception was -98.95%, roughly equal to the maximum TGTX drawdown of -99.52%. Use the drawdown chart below to compare losses from any high point for PAYS and TGTX.


Loading charts...

Drawdown Indicators


PAYSTGTXDifference

Max Drawdown

Largest peak-to-trough decline

-98.95%

-99.52%

+0.57%

Max Drawdown (1Y)

Largest decline over 1 year

-55.59%

-26.85%

-28.74%

Max Drawdown (3Y)

Largest decline over 3 years

-64.60%

-42.06%

-22.54%

Max Drawdown (5Y)

Largest decline over 5 years

-64.60%

-89.47%

+24.87%

Max Drawdown (10Y)

Largest decline over 10 years

-93.09%

-93.19%

+0.10%

Current Drawdown

Current decline from peak

-50.08%

-77.71%

+27.63%

Average Drawdown

Average peak-to-trough decline

-69.26%

-91.31%

+22.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

29.72%

13.66%

+16.06%

Volatility

PAYS vs. TGTX - Volatility Comparison

PaySign, Inc. (PAYS) has a higher volatility of 13.28% compared to TG Therapeutics, Inc. (TGTX) at 12.23%. This indicates that PAYS's price experiences larger fluctuations and is considered to be riskier than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PAYSTGTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.28%

12.23%

+1.05%

Volatility (6M)

Calculated over the trailing 6-month period

52.10%

33.96%

+18.14%

Volatility (1Y)

Calculated over the trailing 1-year period

70.23%

47.22%

+23.01%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

67.40%

87.68%

-20.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

75.75%

86.71%

-10.96%

Dividends

PAYS vs. TGTX - Dividend Comparison

Neither PAYS nor TGTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

PAYS vs. TGTX - Financials Comparison

This section allows you to compare key financial metrics between PaySign, Inc. and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

PAYS vs. TGTX - Profitability Comparison

The chart below illustrates the profitability comparison between PaySign, Inc. and TG Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

PAYS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, PaySign, Inc. reported a gross profit of 18.22M and revenue of 28.04M. Therefore, the gross margin over that period was 65.0%.

TGTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.

PAYS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, PaySign, Inc. reported an operating income of 6.67M and revenue of 28.04M, resulting in an operating margin of 23.8%.

TGTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.

PAYS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, PaySign, Inc. reported a net income of 5.44M and revenue of 28.04M, resulting in a net margin of 19.4%.

TGTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.


Frequently Asked Questions


PAYS and TGTX have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PAYS has higher volatility (13.28%) compared to TGTX (12.23%). In terms of maximum drawdown, PAYS dropped -98.95% vs TGTX's -99.52%.

TGTX currently has the higher Sharpe Ratio (0.99 vs 0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PAYS and TGTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer